These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6111982)

  • 21. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)-amino]propoxy)benzeneacetamide (KF-4317).
    Kubo K; Nakamura J; Karasawa A; Shuto K; Nakamizo N
    Arzneimittelforschung; 1983; 33(7):926-31. PubMed ID: 6138045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
    Kubo K; Ikeda J; Nakamura J; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta adrenoceptor blocking properties of MK-761.
    Sweet CS; Hall RA; Columbo JM; Wenger HC; Backlund E; Morgan G; Gaul SL; Scriabine A
    J Pharmacol Exp Ther; 1979 Oct; 211(1):195-9. PubMed ID: 40012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
    Iuzhakov SD; Sokolov SD; Vinogradova SM
    Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 31. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
    Masumoto S; Inoue H; Maruyama Y
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.
    Harting J; Becker KH; Bergmann R; Bourgois R; Enenkel HJ; Fuchs A; Jonas R; Lettenbaur H; Minck KO; Schelling P
    Arzneimittelforschung; 1986 Feb; 36(2):200-8. PubMed ID: 2870720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacological characterization of beta-sympathicolytic substances.
    Saameli K
    Indian Heart J; 1972 Jun; 24():Suppl 1:146-56. PubMed ID: 4147272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metoprolol--a new cardioselective beta adrenoceptor antagonist in experimental cardiac arrhythmias.
    Sivam SP; Seth SD
    Indian J Med Res; 1978 Jul; 68():176-82. PubMed ID: 700845
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the circulatory pharmacology of the new beta-adrenergic agent dobutamine (author's transl)].
    Femmer K; Heer S
    Pharmazie; 1980; 35(9):558-63. PubMed ID: 7433510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.